logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Takeshi Kawakami

Shizuoka Cancer Center
H指数:11
被引数:599

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study

奥塞罗研究：一项关于regorafenib和FTD/TPI在转移性结直肠癌中治疗顺序的前瞻性观察研究

British Journal of Cancer
IF6.8
2026-09-290
PRE
Takeshi Kawakami; Toshiki Masuishi; Tetsutaro Hamano; Akihiko Chida; Seiichiro Mitani; Hisateru Yasui; Atsushi Ishiguro; Takayuki Ando; Kentaro Sawada; Kazuaki Harada; Naoki Takahashi; Shogen Boku; Tomomi Kashiwada; Taito Esaki; Ayumu Yoshikawa; Keiji Sugiyama; Kouji Yamamoto; Hironaga Satake; Satoshi Yuki; Kentaro Yamazaki; Eiji Oki
A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)

多中心II期临床试验评估雷莫芦单抗联合伊立替康治疗早期复发的胃癌（在多西他赛联合S-1疗法辅助化疗期间或之后）：RAMIEL试验（OGSG1901）

Gastric Cancer
IF5.1
2026-09-160
OAAI
Toshifumi Yamaguchi; Ryohei Kawabata; Yusuke Akamaru; Hidekazu Hirano; Keijiro Sugimura; Yasuhiro Miyazaki; Yoshihiro Kakeji; Yosuke Kito; Takashi Nomura; Takeshi Kawakami; Masahiro Tanemura; Atsushi Takeno; Hiroyuki Okuda; Tomohiro Matsushima; Toshio Shimokawa; Yukinori Kurokawa; Shunji Endo; Narikazu Boku; Taroh Satoh
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G

晚期胃癌伴严重腹膜转移患者mFOLFOX6方案的II期研究（WJOG10517G），包括与JCOG1108/WJOG7312G的个体患者数据比较

Gastric Cancer
IF5.1
2026-08-270
OAAI
Toshiki Masuishi; Hiroki Hara; Takayuki Ando; Takeshi Kawakami; Yoshiyuki Yamamoto; Naotoshi Sugimoto; Kazuhiro Shiraishi; Taito Esaki; Yuji Negoro; Takao Tsuzuki; Hiroaki Sawai; Masato Nakamura; Takashi Inagaki; Yudai Shinohara; Kentaro Kawakami; Seiichiro Mitani; Kenji Tsuchihashi; Chihiro Kondoh; Hiroo Katsuya; Osamu Maeda; Yuriko Fujita; Kenichi Yoshimura; Masanori Terashima; Takako Eguchi Nakajima; Kei Muro
Gender-age-physiology stage and body mass index are useful predictors of nintedanib discontinuation and prognosis in patients with idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung diseases

性别、年龄、生理阶段和体重指数是预测特发性肺纤维化和进行性纤维化间质性肺疾病患者尼达尼布停药及预后的有用指标。

BMC Pulmonary Medicine
IF2.8
2025-12-050
OAAI
Kai Yazaki; Masashi Matsuyama; Hiroaki Satoh; Kunihiko Miyazaki; Naoki Arai; Yukio Ishii; Takeo Endo; Takayuki Kaburagi; Takeshi Kawakami; Hiroaki Iijima; Toshiaki Motegi; Shigen Hayashi; Norihiro Kikuchi; Tohru Sakamoto; Nobuyuki Hizawa
FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancer

FGFR2-IIIc亚型检测揭示了在胃癌和胃食管结合部癌中的预后普遍性及其与间质转化的功能联系

ESMO Open
IF8.3
2025-10-300
OAAI
T. Hashimoto; N. Iida; S. Kadowaki; A. Makiyama; N. Machida; N. Takahashi; S. Boku; T. Kudo; E. Oki; K. Ohtsubo; T. Kawakami; N. Okano; Y. Komatsu; S. Yuki; N. Sakamoto; T. Kuwata; R. Yamashita; M. Amisaki; T. Shibuki; M. Imai; T. Fujisawa; Y. Nakamura; H. Bando; K. Shitara; T. Yoshino
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)

nab-紫杉醇联合雷莫芦单抗联合nivolumab治疗一线治疗进展后不可切除的晚期或复发性胃癌的II期试验，包括氟嘧啶，铂和anti-PD-1/PD-L1抗体 (PADDLE)

BMC CANCER
IF3.4
2025-02-040
OAAI
Hirano, Hidekazu; Takahashi, Naoki; Amanuma, Yusuke; Suzuki, Nobumi; Takahari, Daisuke; Kawakami, Takeshi; Kudo-Saito, Chie; Nagashima, Kengo; Boku, Narikazu; Kato, Ken; Shoji, Hirokazu
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS

WJOG13320GPS: 微卫星不稳定性高转移性或复发性胃癌和食管胃结合部癌的患病率和临床病理特征

GASTRIC CANCER
IF5.1
2024-12-310
PRE
Komori, Azusa; Hironaka, Shuichi; Kadowaki, Shigenori; Mitani, Seiichiro; Furuta, Mitsuhiro; Kawakami, Takeshi; Makiyama, Akitaka; Takegawa, Naoki; Sugiyama, Keiji; Hirano, Hidekazu; Ando, Takayuki; Matsushima, Tomohiro; Chida, Akihiko; Kashiwada, Tomomi; Komoda, Masato; Matsumoto, Toshihiko; Oda, Hisanobu; Yabusaki, Hiroshi; Kawakami, Hisato; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei

研究方向

暂未获取到该数据
K
Kentaro Yamazaki
H 指数:46论文数:557被引数:1.4万
H
Hirofumi Yasui
H 指数:33论文数:255被引数:4,876
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
T
Tomoya Yokota
H 指数:37论文数:345被引数:7,891
Y
Yusuke Onozawa
H 指数:28论文数:205被引数:2,782
T
Takahiro Tsushima
H 指数:33论文数:252被引数:4,673
A
Akiko Todaka
H 指数:22论文数:173被引数:1,546
S
Satoshi Hamauchi
H 指数:20论文数:115被引数:1,128
T
Toshiki Masuishi
H 指数:24论文数:324被引数:2,986
H
Hiromichi Shirasu
H 指数:12论文数:55被引数:1,037